Getein Biotech: Innovation on Display at TBS！ Event Highlights From October 28th to 31st, 2025, Getein Biotech made a successful appearance at the TBS International Laboratory Medicine Summit in Istanbul, Türkiye. In this vibrant city bridging Europe and Asia, we experienced firsthand the dynamic pulse of the regional market. At this prestigious academic gathering where East meets West, Getein showcased two core platforms—fully automated chemiluminescence and molecular diagnostics—demonstrating the company's technological innovation capabilities and product strength while injecting fresh momentum into regional collaboration.     Getein in the Spotlight Throughout the exhibition, Getein Biotech built precise connections with client needs through professional expertise. With detailed equipment demonstrations and in-depth technical exchanges, our cutting-edge technological level and innovative designs quickly made us a focal point of the event. On this platform where Eastern and Western medical technologies converge, we established solid and reliable bonds of trust.     Our products impressed attending experts and partners with their exceptional accuracy, efficient performance, and reliable stability, fully demonstrating the company's forward-looking technology planning and innovative capabilities.     Future Forward     This participation was not merely a product exhibition but a strategic effort to deepen our engagement in the Türkiye's market. Getein Biotech will continue to cultivate this land rich in ancient civilization, using innovation as our foundation and partnership as our link. We value every connection and dialogue established during the summit. Moving forward, Getein will continue to drive innovation, strengthen trust and cooperation with global clients, and contribute our professional expertise to enhancing human health outcomes.

Getein Shines at Global Health Exhibition 2025！ Retrospect Getein Biotech presented its advanced diagnostic solutions at the Global Health Exhibition, held from October 27-30, 2025 in Riyadh, Saudi Arabia. As a highlighted exhibitor, our company showcased its chemiluminescence and immunofluorescence platforms, demonstrating its commitment to innovation in in-vitro diagnostics.     Building Connections Getein Biotech’s booth became a hub for international professionals throughout the event. Through live product demonstrations and in-depth technical discussions, our team engaged in multiple rounds of interaction with medical practitioners, institutional representatives, and industry partners from around the world.      On-site feedback was highly positive, with many visitors expressing strong interest in product performance and practical application scenarios.     Local Market Insights The exhibition provided valuable insights into the Middle Eastern medical market. Through in-depth communication with local healthcare providers, Getein has developed a more precise understanding of the characteristics and needs of the regional healthcare system, laying a solid foundation for future collaboration.     Looking Ahead This participation marked an important step in Getein Biotech’s presence in the Middle East. Through in-depth communication with healthcare professionals and partners in the region, we have gained a clearer understanding of local demands and development trends.      Moving forward, Getein will continue to dedicate efforts to R&D and product innovation, delivering diagnostic solutions better tailored to local scenarios—contributing to enhanced healthcare accessibility and quality across the region.   See you soon!

Getein Biotech Shines at WHX Nairobi Exhibition in Kenya!   Retrospect From October 22nd to 24th, Getein Biotech successfully participated in the WHX Nairobi & WHX Labs Nairobi exhibition in Kenya. The event served as an excellent platform, allowing us to engage deeply with clients and partners from East Africa. It was a fruitful opportunity to strengthen existing relationships, build new connections, and jointly explore the vast potential of the regional market.     Exhibition Highlights The exhibition stand attracted consistent interest, serving as a dynamic setting for productive dialogue. A robust product portfolio, tailored to diverse diagnostic needs, was presented and drew considerable attention. Visitors took an active part in consultations and live demonstrations, earning strong recognition from industry experts and partners who commended the products’ professional performance and precise market positioning.     Star Products in the Spotlight The featured product lineup, designed for a variety of diagnostic scenarios, received notable acclaim:   MAGICL 6000 Chemiluminescence Immunoassay Analyzer:    This star product once again captured the spotlight,    impressing attendees with its compact design, high    throughput, full automation, and fast, accurate results, underscoring Getein's innovation in high-end diagnostic technology.   Getein 1160 & Getein 1150 Immunofluorescence Quantitative Analyzer:   Reliable solutions for point-of-care testing, which are appreciated for their excellent sensitivity and ease of use, meet diverse needs in primary healthcare and precise diagnostics.     BHA-5000 Hematology:    Recognized for its efficient testing speed and reliable stability, providing a robust tool for clinical hematology analysis.     Looking Ahead Participation in the Nairobi exhibition went beyond a successful showcase — it represented a strategic move to further embed the company within the East African market. Insightful exchanges with medical professionals from Kenya and neighboring regions provided valuable local perspectives, establishing a solid groundwork for developing more customized solutions in the future.     We wish to express our profound gratitude to every partner, both new and established, who honored us with a visit. United by a global vision of shared success, Getein Biotech anticipates future collaboration with our African partners — working together to foster advanced diagnostic technologies and enhance healthcare outcomes across the region.  Eagerly, we anticipate our next meeting and continued progress together.